Physician profile
Nathan A Blanton
NPI 1760836506
$10,680.83
in general payments reported to CMS, 2019-2025
17 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,341 · 2020: $1,014 · 2021: $3,708 · 2022: $2,334 · 2023: $709 · 2024: $1,188 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,283.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,630.55 | 2019-2025 | Augment Injectable, Viaflow, Citrefix |
| Legacy Ortho LLC | $1,200.00 | 2022 | |
| Kerecis Limited | $513.81 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Smith+Nephew, INC. | $322.90 | 2020-2024 | Grafix Pl, Oasis, Stravix |
| Biotissue Holdings INC. | $302.72 | 2024 | |
| Acera Surgical, INC. | $138.01 | 2024 | Restrata Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $119.99 | 2019 | |
| Organogenesis INC. | $118.49 | 2019-2022 | |
| Misonix INC | $104.63 | 2020-2021 | |
| Paragon 28, INC. | $46.76 | 2019-2020 | |
| Pfizer INC. | $40.54 | 2020 | |
| Treace Medical Concepts, INC. | $37.29 | 2023-2024 | |
| Bioventus LLC | $33.95 | 2022 | |
| Reapplix INC. | $21.43 | 2025 | 3c Patch Kit - Box |
| Mimedx Group, INC. | $20.98 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $17.32 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Acell, INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Blanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.